Desferrioxamine enhances aids‐associated Kaposi's sarcoma tumor development in a xenograft model
Thierry Simonart(IS practice), Robert Snoeck(Rega Institute for Medical Research), Jean‐Christophe Noël(Institut Pasteur), Joost J. van den Oord(KU Leuven), Chantale Degraef(Erasmus Hospital), Michel Heenen(Erasmus Hospital), Jean‐Paul Van Vooren(Université Libre de Bruxelles), Johan R. Boelaert(AZ Sint-Jan), Graciela Andreï(Rega Institute for Medical Research), Philippe Hermans(Centre Hospitalier Universitaire de Saint-Pierre), Erik De Clercq(Rega Institute for Medical Research)
Cited by 15
Related Papers
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
|JNCI Journal of the National Cancer Institute|2006|480
European Evidence‐based (S3) Guidelines for the Treatment of Acne
|Journal of the European Academy of Dermatology and Venereology|2012|422